首页> 美国卫生研究院文献>The Pan African Medical Journal >L’observance thérapeutique: un autre défi à relever chez l’hémodialysé chronique
【2h】

L’observance thérapeutique: un autre défi à relever chez l’hémodialysé chronique

机译:治疗依从性:慢性血液透析患者要面对的另一挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Poor compliance with therapy is frequently encountered in most of patients with chronic diseases. It increases the risk of morbi-mortality and healthcare costs. Patients on chronic haemodialysis often have poor compliance with treatment. This study aims to assess the level of compliance with treatment in our patients on chronic hemodialysis and to identify the predictive factors of poor compliance with treatment. We conducted a cross-sectional study at the Oujda Hospital in November 2011. The compliance with treatment was measured using a questionnaire: the compliance evaluation test (CET) assessed the compliance with medication treatment and diet. A rate of 85% was retained arbitrarily as a threshold for good compliance with treatment. Patient in a zone of partial adherence had a rate between 57% and 85% while a lower rate (57%) indicated poor compliance with treatment. Different demographic and clinicobiologic parameters were analyzed and predictive factors for good and poor compliance with treatment were identified. Our study involved 101 patients on chronic haemodialysis; the sex ratio was 1.2, the average age of patients was 15.6 years. CET showed that 23.4% of patients had good compliance with treatment, 39.4% partial compliance with treatment and 37.2% poor compliance with treatment. Statistical analysis showed that poor compliance with treatment was associated with a lower socio-economic and intellectual status, with co-morbidities and with long term hemodialysis. Good compliance with treatment was observed in very old patients helped by a third person, taking a reduced number of medications, with a higher intellectual level.
机译:大多数慢性病患者经常会遇到治疗依从性差的情况。它增加了死亡率和医疗费用的风险。进行慢性血液透析的患者通常对治疗的依从性较差。本研究旨在评估慢性血液透析患者对治疗依从性的水平,并确定对治疗依从性较差的预测因素。我们于2011年11月在Oujda医院进行了横断面研究。使用问卷调查了对治疗的依从性:依从性评估测试(CET)评估了对药物治疗和饮食的依从性。任意保留85%的比率作为对治疗的良好依从性的阈值。处于部分依从区域的患者的比率在57%至85%之间,而较低的比率(57%)表明对治疗的依从性较差。分析了不同的人口统计学和临床​​生物学参数,并确定了治疗依从性的良好和不良预测因素。我们的研究涉及101例进行慢性血液透析的患者。性别比为1.2,患者平均年龄为15.6岁。 CET显示,23.4%的患者对治疗的依从性良好,39.4%的患者对治疗的依从性和37.2%的患者对治疗的依从性较差。统计分析表明,对治疗的依从性差与较低的社会经济和智力状况,合并症和长期血液透析有关。在第三人的帮助下,老年患者观察到对治疗的良好依从性,减少了药物的使用,提高了智力水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号